{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T17:18:49Z","timestamp":1783703929402,"version":"3.55.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Opinion in Pharmacology"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1016\/j.coph.2009.06.007","type":"journal-article","created":{"date-parts":[[2009,7,3]],"date-time":"2009-07-03T09:44:09Z","timestamp":1246614249000},"page":"427-433","source":"Crossref","is-referenced-by-count":31,"title":["Inflammation, cancer, and bone loss"],"prefix":"10.1016","volume":"9","author":[{"given":"Yousef","family":"Abu-Amer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coph.2009.06.007_bib1","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.0105-2896.2005.00338.x","article-title":"Rheumatic diseases: the effects of inflammation on bone","volume":"208","author":"Walsh","year":"2005","journal-title":"Immunol Rev"},{"key":"10.1016\/j.coph.2009.06.007_bib2","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ccr.2007.10.005","article-title":"Inflammation and cancer: a double-edged sword","volume":"12","author":"Hagemann","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.coph.2009.06.007_bib3","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2353\/ajpath.2007.060834","article-title":"Osteoclasts: what do they do and how do they do it?","volume":"170","author":"Teitelbaum","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1016\/j.coph.2009.06.007_bib4","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","article-title":"Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation","volume":"93","author":"Lacey","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.coph.2009.06.007_bib5","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1002\/art.11150","article-title":"Osteoprotegerin protects against generalized bone loss in tumor necrosis factor-transgenic mice","volume":"48","author":"Schett","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.coph.2009.06.007_bib6","first-page":"276","article-title":"RANK, RANKL and OPG in inflammatory arthritis and periprosthetic osteolysis","volume":"4","author":"Ritchlin","year":"2004","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"10.1016\/j.coph.2009.06.007_bib7_1","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/16852","article-title":"OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis","volume":"397","author":"Kong","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.coph.2009.06.007_bib8","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/978-0-387-70630-6_12","article-title":"TRAFs in RANK signaling","volume":"597","author":"Darnay","year":"2007","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.coph.2009.06.007_bib9","first-page":"347","article-title":"Advances in osteoclast differentiation and function.","volume":"5","author":"Abu-Amer","year":"2005","journal-title":"Curr Drug Targets: Immune, Endocr Metab Disorders"},{"key":"10.1016\/j.coph.2009.06.007_bib10_1","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1080\/08916930701694543","article-title":"Role of the NF-kappaB axis in immune modulation of osteoclasts and bone loss","volume":"41","author":"Abu-Amer","year":"2008","journal-title":"Autoimmunity"},{"key":"10.1016\/j.coph.2009.06.007_bib11","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.bbapap.2003.11.016","article-title":"Targeting the JNK MAPK cascade for inhibition: basic science and therapeutic potential","volume":"1697","author":"Bogoyevitch","year":"2004","journal-title":"Biochim Biophys Acta (BBA): Proteins Proteomics"},{"key":"10.1016\/j.coph.2009.06.007_bib12","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0736-0266(03)00156-6","article-title":"NF-kB signaling blockade abolishes implant particle-induced osteoclastogenesis","volume":"22","author":"Clohisy","year":"2004","journal-title":"J Orthop Res"},{"key":"10.1016\/j.coph.2009.06.007_bib13","doi-asserted-by":"crossref","first-page":"5547","DOI":"10.4049\/jimmunol.171.10.5547","article-title":"Direct inhibition of NF-kB blocks bone erosion associated with inflammatory arthritis","volume":"171","author":"Clohisy","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.coph.2009.06.007_bib14","doi-asserted-by":"crossref","first-page":"3482","DOI":"10.1101\/gad.11.24.3482","article-title":"Requirement for NF-kB in osteoclast and B-cell development","volume":"11","author":"Franzoso","year":"1997","journal-title":"Genes Dev"},{"key":"10.1016\/j.coph.2009.06.007_bib15","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1006\/scbi.1997.0060","article-title":"Genetic approaches to study Rel\/NF-kB\/IkB function in mice","volume":"8","author":"Attar","year":"1997","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.coph.2009.06.007_bib16","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nrg1122","article-title":"Genetic regulation of osteoclast development and function","volume":"4","author":"Teitelbaum","year":"2003","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.coph.2009.06.007_bib17","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nri2094","article-title":"Cytokines in the pathogenesis of rheumatoid arthritis","volume":"7","author":"McInnes","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.coph.2009.06.007_bib18","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.2174\/1381612054865046","article-title":"New insights in the mechanism of bone loss in arthritis","volume":"11","author":"Schett","year":"2005","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.coph.2009.06.007_bib19_1","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S1097-2765(00)80232-4","article-title":"TRANCE, a TNF family member, activates Akt\/PKB through a signaling complex involving TRAF6 and c-src","volume":"4","author":"Wong","year":"1999","journal-title":"Mol Cell"},{"key":"10.1016\/j.coph.2009.06.007_bib20","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1600-065X.1999.tb01315.x","article-title":"On the role of TNF and receptors in models of multiorgan failure, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease","volume":"169","author":"Kollias","year":"1999","journal-title":"Immunol Rev"},{"key":"10.1016\/j.coph.2009.06.007_bib21","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1084\/jem.20061775","article-title":"Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction","volume":"203","author":"Sato","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.coph.2009.06.007_bib22","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1349-7006.2007.00690.x","article-title":"Transforming growth factor beta derived from bone matrix promotes cell proliferation of prostate cancer and osteoclast activation-associated osteolysis in the bone microenvironment","volume":"99","author":"Sato","year":"2008","journal-title":"Cancer Sci"},{"key":"10.1016\/j.coph.2009.06.007_bib23","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s10555-006-9035-x","article-title":"Breast cancer bone metastasis and current small therapeutics","volume":"25","author":"Cicek","year":"2006","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.coph.2009.06.007_bib24_1","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1158\/1078-0432.CCR-05-1849","article-title":"Prostate-specific antigen modulates genes involved in bone remodeling and induces osteoblast differentiation of human osteosarcoma cell line SaOS-2","volume":"12","author":"Nadiminty","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.coph.2009.06.007_bib25","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1182\/blood-2008-03-145169","article-title":"The role of Dickkopf-1 in bone development, homeostasis, and disease","volume":"113","author":"Pinzone","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.coph.2009.06.007_bib26_1","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.ccr.2005.04.013","article-title":"MMP-7 promotes prostate cancer-induced osteolysis via the solubilization of RANKL","volume":"7","author":"Lynch","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.coph.2009.06.007_bib27_1","first-page":"17","article-title":"The IKK NF-kB system: a treasure trove for drug development","volume":"3","author":"Karin","year":"2004","journal-title":"Nat Rev"},{"key":"10.1016\/j.coph.2009.06.007_bib28_1","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/41493","article-title":"A cytokine-responsive I-\u03baB kinase that activates the transcription factor NF-\u03baB","volume":"388","author":"DiDonato","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.coph.2009.06.007_bib29","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1126\/science.278.5339.860","article-title":"IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation","volume":"278","author":"Mercurio","year":"1997","journal-title":"Science (New York, NY)"},{"key":"10.1016\/j.coph.2009.06.007_bib30","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0092-8674(00)80344-X","article-title":"Identification and characterization of an I-\u03baB kinase","volume":"90","author":"Regnier","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.coph.2009.06.007_bib31","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0092-8674(00)80413-4","article-title":"NF-kB activation:: The IkB kinase revealed?","volume":"91","author":"Stancovski","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.coph.2009.06.007_bib32","doi-asserted-by":"crossref","first-page":"45992","DOI":"10.1074\/jbc.M206494200","article-title":"Characterization of the Ikappa B-kinase NEMO binding domain","volume":"277","author":"May","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coph.2009.06.007_bib33","doi-asserted-by":"crossref","first-page":"37219","DOI":"10.1074\/jbc.C400258200","article-title":"The IkappaB kinase (IKK) inhibitor, NEMO-binding domain peptide, blocks osteoclastogenesis and bone erosion in inflammatory arthritis","volume":"279","author":"Dai","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coph.2009.06.007_bib34","doi-asserted-by":"crossref","first-page":"54841","DOI":"10.1074\/jbc.M406392200","article-title":"Osteoclast differentiation is impaired in the absence of IkB kinase-alpha","volume":"279","author":"Chaisson","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coph.2009.06.007_bib35","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1084\/jem.20042081","article-title":"IkB kinase-beta, but not IKK-alpha, is a critical mediator of osteoclast survival and is required for inflammation-induced bone loss","volume":"201","author":"Ruocco","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.coph.2009.06.007_bib36","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.cell.2007.03.056","article-title":"Proinflammatory stimuli induce IKK[alpha]-mediated phosphorylation of PIAS1 to restrict inflammation and immunity","volume":"129","author":"Liu","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.coph.2009.06.007_bib37","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/cr.2008.30","article-title":"The IkappaB kinase\u2014a bridge between inflammation and cancer","volume":"18","author":"Karin","year":"2008","journal-title":"Cell Res"},{"key":"10.1016\/j.coph.2009.06.007_bib38_1","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nm1519","article-title":"NF-kappaB in breast cancer cells promotes osteolytic bone metastasis by inducing osteoclastogenesis via GM-CSF","volume":"13","author":"Park","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.coph.2009.06.007_bib39","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/nm1054","article-title":"Selective inhibition of NF-kappa B blocks osteoclastogenesis and prevents inflammatory bone destruction in vivo","volume":"10","author":"Jimi","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.coph.2009.06.007_bib40","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1126\/science.289.5484.1550","article-title":"Selective Inhibition of NF-kappa B activation by a peptide that blocks the interaction of NEMO with the Ikappa B kinase complex","volume":"289","author":"May","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.coph.2009.06.007_bib41","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/978-0-387-72009-8_16","article-title":"Control of osteoclast activity and bone loss by IKK subunits: new targets for therapy","volume":"602","author":"Ruocco","year":"2007","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.coph.2009.06.007_bib42","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S1471-4914(01)02154-2","article-title":"NEMO\/IKK-gamma: linking NF-kB to human disease","volume":"7","author":"Courtois","year":"2001","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.coph.2009.06.007_bib43","doi-asserted-by":"crossref","first-page":"e615","DOI":"10.1542\/peds.2004-1754","article-title":"NEMO mutations in 2 unrelated boys with severe infections and conical teeth","volume":"115","author":"Ku","year":"2005","journal-title":"Pediatrics"},{"key":"10.1016\/j.coph.2009.06.007_bib44","doi-asserted-by":"crossref","first-page":"R1040","DOI":"10.1016\/j.cub.2004.11.040","article-title":"Inflammatory diseases: is ubiquitinated NEMO at the Hub?","volume":"14","author":"Burns","year":"2004","journal-title":"Curr Biol"},{"key":"10.1016\/j.coph.2009.06.007_bib45","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/ncb1384","article-title":"Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-kappaB activation","volume":"8","author":"Wu","year":"2006","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.coph.2009.06.007_bib46","doi-asserted-by":"crossref","first-page":"7107","DOI":"10.4049\/jimmunol.180.11.7107","article-title":"Cutting edge: K63-linked polyubiquitination of NEMO modulates TLR signaling and inflammation in vivo","volume":"180","author":"Ni","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.coph.2009.06.007_bib47","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1016\/j.cub.2004.12.032","article-title":"The Crohn's disease protein, NOD2, requires RIP2 in order to induce ubiquitinylation of a novel site on NEMO","volume":"14","author":"Abbott","year":"2004","journal-title":"Curr Biol"},{"key":"10.1016\/j.coph.2009.06.007_bib48","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/mc.20217","article-title":"NF-kappaB and cancer: mechanisms and targets","volume":"45","author":"Karin","year":"2006","journal-title":"Mol Carcinogen"},{"key":"10.1016\/j.coph.2009.06.007_bib49","doi-asserted-by":"crossref","first-page":"24546","DOI":"10.1074\/jbc.M800434200","article-title":"Defective osteoclastogenesis by IKKbeta-null precursors is a result of receptor activator of NF-kappaB ligand (RANKL)-induced JNK-dependent apoptosis and impaired differentiation","volume":"283","author":"Otero","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coph.2009.06.007_bib50","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.4049\/jimmunol.179.5.2681","article-title":"Cutting edge: the I{kappa}B kinase (IKK) inhibitor, NEMO-binding domain peptide. Blocks inflammatory injury in murine colitis","volume":"179","author":"Shibata","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.coph.2009.06.007_bib51","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1084\/jem.20030116","article-title":"The I-kappaB function of NF-kappaB2 p100 controls stimulated osteoclastogenesis","volume":"198","author":"Novack","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.coph.2009.06.007_bib52","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1038\/nature03491","article-title":"IKK-alpha- limits macrophage NF-kB activation and contributes to the resolution of inflammation","volume":"434","author":"Lawrence","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.coph.2009.06.007_bib53_1","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/nature05656","article-title":"Nuclear cytokine-activated IKKalpha controls prostate cancer metastasis by repressing Maspin","volume":"446","author":"Luo","year":"2007","journal-title":"Nature"}],"container-title":["Current Opinion in Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489209000800?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489209000800?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,18]],"date-time":"2018-12-18T15:56:51Z","timestamp":1545148611000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471489209000800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":53,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["S1471489209000800"],"URL":"https:\/\/doi.org\/10.1016\/j.coph.2009.06.007","relation":{},"ISSN":["1471-4892"],"issn-type":[{"value":"1471-4892","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8]]}}}